Review article · 2019 · Open access
Cost-Effectiveness Evaluations of Psychological Therapies for Schizophrenia and Bipolar Disorder: A Systematic Review
International Journal of Technology Assessment in Health Care, 35(4), 317–326 · Published 22 July 2019 · DOI 10.1017/s0266462319000448
In brief
“Cost-Effectiveness Evaluations of Psychological Therapies for Schizophrenia and Bipolar Disorder: A Systematic Review” is a 2019 review article by Gemma Shields and 4 co-authors, published in International Journal of Technology Assessment in Health Care. OpenAlex counts 29 citations as of 20 November 2026. It is open access: the full text is free to read at Research Explorer (The University of Manchester).
- Citations
- 29
- Most cited in
- 2026 (7)
- Field-weighted impact
- 0.79
- References
- 63
- Authors
- 5
Abstract
OBJECTIVES: This review aims to assess the cost-effectiveness of psychological interventions for schizophrenia/bipolar disorder (BD), to determine the robustness of current evidence and identify gaps in the available evidence. METHODS: Electronic searches (PsycINFO, MEDLINE, Embase) identified economic evaluations relating incremental cost to outcomes in the form of an incremental cost-effectiveness ratio published in English since 2000. Searches were concluded in November 2018. Inclusion criteria were: adults with schizophrenia/BD; any psychological/psychosocial intervention (e.g., psychological therapy and integrated/collaborative care); probability of cost-effectiveness at explicitly defined thresholds reported. Comparators could be routine practice, no intervention, or alternative psychological therapies. Screening, data extraction, and critical appraisal were performed using pre-specified criteria and forms. Results were summarized qualitatively. The protocol was registered on the PROSPERO database (CRD42017056579). RESULTS: Of 3,864 studies identified, 12 met the criteria for data extraction. All were integrated clinical and economic randomized controlled trials. The most common intervention was cognitive behavioral therapy (CBT, 6/12 studies). The most common measure of health benefit was the quality-adjusted life-year (6/12). Follow-up ranged from 6 months to 5 years. Interventions were found to be cost-effective in most studies (9/12): the probability of cost-effectiveness ranged from 35-99.5 percent. All studies had limitations and demonstrated uncertainty (particularly related to incremental costs). CONCLUSIONS: Most studies concluded psychological interventions for schizophrenia/BD are cost-effective, including CBT, although there was notable uncertainty. Heterogeneity across studies makes it difficult to reach strong conclusions. There is a particular need for more evidence in the population with BD and for longer-term evidence across both populations.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Shields, G., Buck, D., Elvidge, J., Hayhurst, K. P., & Davies, L. M. (2019). Cost-Effectiveness Evaluations of Psychological Therapies for Schizophrenia and Bipolar Disorder: A Systematic Review. International Journal of Technology Assessment in Health Care, 35(4), 317–326. https://doi.org/10.1017/s0266462319000448
MLA 9
Shields, Gemma, et al. “Cost-Effectiveness Evaluations of Psychological Therapies for Schizophrenia and Bipolar Disorder: A Systematic Review.” International Journal of Technology Assessment in Health Care, vol. 35, no. 4, 2019, pp. 317–326. https://doi.org/10.1017/s0266462319000448.
Chicago
Shields, Gemma, Deborah Buck, Jamie Elvidge, Karen Petra Hayhurst, and Linda Mary Davies. 2019. “Cost-Effectiveness Evaluations of Psychological Therapies for Schizophrenia and Bipolar Disorder: A Systematic Review.” International Journal of Technology Assessment in Health Care 35 (4): 317–326. https://doi.org/10.1017/s0266462319000448.
Harvard
Shields, G. et al. (2019) ‘Cost-Effectiveness Evaluations of Psychological Therapies for Schizophrenia and Bipolar Disorder: A Systematic Review’, International Journal of Technology Assessment in Health Care, 35(4), pp. 317–326. doi:10.1017/s0266462319000448.
IEEE
G. Shields, D. Buck, J. Elvidge, K. P. Hayhurst, and L. M. Davies, “Cost-Effectiveness Evaluations of Psychological Therapies for Schizophrenia and Bipolar Disorder: A Systematic Review,” International Journal of Technology Assessment in Health Care, vol. 35, no. 4, pp. 317–326, 2019, doi: 10.1017/s0266462319000448.
BibTeX
@article{shields2019cost,
title = {{Cost-Effectiveness Evaluations of Psychological Therapies for Schizophrenia and Bipolar Disorder: A Systematic Review}},
author = {Shields, Gemma and Buck, Deborah and Elvidge, Jamie and Hayhurst, Karen Petra and Davies, Linda Mary},
journal = {International Journal of Technology Assessment in Health Care},
year = {2019},
volume = {35},
number = {4},
pages = {317--326},
doi = {10.1017/s0266462319000448},
url = {https://doi.org/10.1017/s0266462319000448}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2020 | 3 | |
| 2021 | 5 | |
| 2022 | 6 | |
| 2023 | 4 | |
| 2024 | 1 | |
| 2025 | 3 | |
| 2026 | 7 |
Its field-weighted citation impact is 0.79: it has been cited 0.79 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- cost-effectiveness
- schizophrenia
- bipolar disorder
- psychotherapy
- psychosocial interventions
- cognitive behavioral therapy
- integrated care
- quality-adjusted life years
Work with this paper
Most-cited papers in Economics, Econometrics and Finance
- Theory of the firm: Managerial behavior, agency costs and ownership structureMichael C. Jensen, William H. Meckling · Journal of Financial Economics · 1976 · 77,585 citations
- Institutions, Institutional Change and Economic PerformanceDouglass C. North · Cambridge University Press eBooks · 1990 · 34,377 citations
- The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.John E. Ware, Cathy Donald Sherbourne · PubMed · 1992 · 33,943 citations
- Some Tests of Specification for Panel Data: Monte Carlo Evidence and an Application to Employment EquationsManuel Arellano, Stephen R. Bond · The Review of Economic Studies · 1991 · 33,778 citations
- Co-Integration and Error Correction: Representation, Estimation, and TestingRobert F. Engle, C.W.J. Granger · Econometrica · 1987 · 32,847 citations
Questions about this paper
How do I cite this paper in APA style?
Shields, G., Buck, D., Elvidge, J., Hayhurst, K. P., & Davies, L. M. (2019). Cost-Effectiveness Evaluations of Psychological Therapies for Schizophrenia and Bipolar Disorder: A Systematic Review. International Journal of Technology Assessment in Health Care, 35(4), 317–326. https://doi.org/10.1017/s0266462319000448
How many times has this paper been cited?
29 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Research Explorer (The University of Manchester): sign in and open the full text from this page.
Who wrote this paper?
Gemma Shields, Deborah Buck, Jamie Elvidge, Karen Petra Hayhurst, Linda Mary Davies.
What is the DOI of this paper?
10.1017/s0266462319000448, permanently at https://doi.org/10.1017/s0266462319000448. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.